A Better Way Forward in Molecular Diagnostics
For 30 years, Cepheid has kept molecular diagnostics moving forward — so answers can reach patients faster, wherever care happens.
Progress in diagnostics doesn’t stand still — and neither do we.
Cepheid was built on the belief that there is always a better way forward. For three decades, that belief has driven us to expand access to molecular testing, improve confidence in results, and help clinicians act sooner for the patients who depend on them.
Always onward means advancing what’s possible — today and for what comes next.
One cartridge. One platform. A connected solution designed to simplify PCR testing and expand access where it’s needed most.
Our testing menu spans key areas of care — from respiratory and blood virology to women’s health, tuberculosis, emerging infectious diseases, oncology, and beyond.
Moving Diagnostics Forward — In Three Meaningful Ways
- Advancing Innovation – We continue to build on decades of molecular expertise—developing solutions that help healthcare systems prepare for what’s next.
- Expanding Reach – From centralized labs to decentralized settings, Cepheid helps bring high‑quality molecular testing closer to the point of need.
- Accelerating Outcomes – When reliable results arrive sooner, clinicians can make informed decisions faster—supporting timely care and better patient management
Cepheid's GeneXpert® System
Experience the GeneXpert Advantage
Easy-to-use random-access system enables on-demand testing, offering flexibility and efficiency over traditional large batch processing. It is a market leader^ in sample-to-answer PCR diagnostic testing with the largest global installed base^ and operates in over 180 countries.
Scalable: Run one to 80 tests at a time
Flexible: Run any combination of tests simultaneously
Cepheid's Xpert® Tests
Empowering Precision Medicine
Lab in a Cartridge™ technology enables sample-to-answer rapid testing with a self-contained, single-use test cartridge that automates nucleic acid extraction, PCR amplification, and target sequence detection.
Let's Move Forward Together
Connect with a Cepheid expert to discuss how the GeneXpert® platform can support your diagnostic needs.
ALWAYS ONWARD
Better Technology. Better Access. Better Results.
Across care settings and specialties, A Better Way means advancing diagnostics through innovation, access, and meaningful insight. Through expert perspectives, these stories show how Cepheid continues Always Onward — supporting Better Technology, expanding Better Access, and enabling Better Results so healthcare teams can keep moving forward, one decision at a time. Cepheid delivers A Better Way. And A Better Way is Always Onward.
WATCH VIDEO
Always Onward: Better Technology for Critical Moments in the ER
In the emergency department, progress depends on diagnostic technology that can keep up with urgency. From Dr. Bryant Boyd’s perspective, Always Onward means relying on molecular diagnostics designed to bring clarity faster — powered by the GeneXpert system and built to support seamless collaboration with the lab. Because in critical moments, Better Technology is designed to keep patient care moving forward.
WATCH VIDEO
Always Onward: Better Access Means Bringing HCV Testing to the Point of Care
Expanding access to HCV testing means bringing diagnostics closer to the patients who need them most. In this expert perspective, Dr. Tony Martinez shares how point‑of‑care testing with Xpert molecular diagnostic tests from Cepheid supports broader access to reliable PCR diagnostics — helping care teams move forward.
WATCH VIDEO
Always Onward: Better Results Begin with Clarity in Pediatric Care
In pediatrics, achieving better results starts with clear, clinically relevant information — especially when symptoms can look the same but require different care decisions. In this expert perspective, Dr. Madison Orsburn shares how Xpert molecular diagnostic tests from Cepheid help support confident clinical decision‑making, so care teams can keep moving forward.
GeneXpert Family of Systems
Standardized yet scalable systems across the healthcare continuum.
- GeneXpert System with Touchscreen - Cepheid's GeneXpert system with touchscreen combines speed, accuracy, simplicity, and an intuitive user interface to deliver PCR results anywhere testing is needed.
- GeneXpert Infinity - Enable a comprehensive menu of tests to be run on a single system by a single operator in a moderately complex, real-time environment.
- GeneXpert Xpress - CLIA waived molecular testing for any healthcare setting — from community hospitals to physician offices, point of care locations, and specialty clinics.
Respiratory Tests
- Xpert Xpress Strep A: Qualitative real-time PCR test providing accurate detection of Group A Streptococcus in as soon as 18 minutes1
- Xpert Xpress CoV-2/Flu/RSV plus*: Actionable rapid respiratory results to meet the challenges of co-circulating respiratory viruses#
- Xpert Xpress CoV-2 plus*: A rapid, near-patient test for the SARS-CoV-2 respiratory virus detection, including emerging variants, to provide timely, effective triage#
- Xpert Xpress Flu#: Accurate and reliable detection of Flu A and Flu B, in as soon as 20 minutes1
Hospital Associated Infections &
Other Infectious Diseases
- Xpert GI Panel: 11 targets. ~74 minutes to results <1 minute hands-on time
- Xpert Carba-R: Detects KPC, NDM, VIM, OXA-48, and IMP in 50 minutes
- Xpert C. difficile: Detection of Clostridium difficile in as soon as 40 minutes1
- Xpert C. difficile/Epi: 45-minute detection & differentiation of Clostridium difficile and the Epidemic 027 strain
- Xpert MRSA/SA Blood Culture: Accurate detection of Staphylococcus aureus (SA) and MRSA in positive blood culture specimens in about an hour
- Xpert MRSA/SA SSTI: Detection of MRSA & SA skin and soft tissue infections in about one hour from nasal swabs
- Xpert MRSA NxG: Accurate, fast, on-demand PCR test that detects Methicillin-resistant Staphylococcus aureus (MRSA) directly from nasal swabs
- Xpert Norovirus: Rapid identification and differentiation of Norovirus GI and GII in less than one hour1
- Xpert SA Nasal Complete: detection of S. aureus and MRSA in about an hour
- Xpert vanA: Rapid and accurate test to assist with VRE surveillance
Women's & Sexual Health
- Xpert Xpress MVP: On-demand PCR test to aid in the diagnosis of bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis in symptomatic women from a single swab within an hour
- Xpert Xpress GBS: Direct intrapartum group B strep results within an hour for labor/delivery
- Xpert GBS LB XC: On-demand antepartum group B strep PCR screening test from lim broth
- Xpert CT/NG: 90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
- Xpert TV: Fast and accurate diagnosis of trichomoniasis for both women and men in about 42 minutes1
TB & Emerging Infectious Diseases
- Xpert HCV: Point-of-care hepatitis C RNA test that enables same-day care
- Xpert Mpox*: On-demand Mpox testing provides accurate point-of-care results in approximately 36 minutes
- Xpert MTB/RIF: Accurate detection of MTB and Rifampin resistance mutations
Oncology & Human Genetics
- Xpert FII & FV: 30-minute test for genetic risk of thrombosis
- Xpert BCR-ABL Ultra: Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)
- Xpert BCR-ABL Ultra p190 (RUO): Quantitative assay for the BCR-ABL minor breakpoint (p190) transcript. For Research Use Only (RUO)
- Xpert NPM1 Mutation (RUO): Quantitative assay of the NPM1 mRNA transcripts (Type A, B, and D) and the ABL1 endogenous control mRNA transcript in EDTA peripheral blood samples. For Research Use Only (RUO)
- Xpert PML RARA (RUO): Quantitative assay for the PML-RARA fusion transcript in EDTA peripheral blood samples. For Research Use Only (RUO)
Always moving forward. Let's take the next step together.
Discover how Cepheid is advancing a better way forward in molecular diagnostics. Connect with your Cepheid trusted partner.
US-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
* These tests have not been FDA cleared or approved. These tests have been authorized for emergency use by FDA under an EUA for use by authorized laboratories. Xpert Xpress CoV-2 plus has been authorized only for the detection of nucleic acids from SARS-CoV-2, and not for any other viruses or pathogens. Xpert Xpress CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. Xpert Mpox has been authorized only for the detection of nucleic acid from monkeypox virus or other non-variola orthopoxviruses, not for any other viruses or pathogens. Xpert Ebloa has been authorized only for the detection of Ebola Zaire virus (detected in the West Africa outbreak in 2014). The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19, monkeypox virus, including non-variola Orthopoxvirus, and/or Ebola virus under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
^ Based on internal install reports.
# In vitro diagnostic device for use in Moderate Complexity or CLIA waived settings.
1. With early assay termination (EAT) for positive results. Full test runtimes are as follows: Xpert Xpress Flu is 30 minutes, Xpert Xpress CoV-2 plus is approximately 30 minutes, Xpert Xpress Strep A is 24 minutes, Xpert TV is 70 minutes, Xpert C. difficile is 43 minutes. With early assay termination for positives when running SARS-CoV-2 only on Xpert Xpress CoV-2/Flu/RSV plus full run time is 36 min. Xpert Norovirus is 88 minutes.
About Cepheid
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most from central laboratories and hospitals to near patient settings.
For more information, visit www.cepheid.com
About | Privacy Policy | Contact | Unsubscribe | Insight Hub
904 Caribbean Drive, Sunnyvale, CA 94089
©2026 Cepheid. All Rights Reserved.